Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Injecting drug use news

Show

From To
Harm reduction prevents HIV, national evidence from Ukraine and Greece shows

Two presentations given at the 20th International AIDS Conference (AIDS 2014), held in Melbourne, Australia, provide significant evidence that harm reduction programmes successfully prevent HIV infection among people

Published
30 July 2014
By
Mara Kardas-Nelson
Interferon-free hepatitis C treatment works for people on methadone or buprenorphine

People with chronic hepatitis C who are using methadone or buprenorphine to manage opiate addiction can be safely and effectively treated with AbbVie's 3D all-oral direct-acting antiviral regimen

Published
25 July 2014
By
Liz Highleyman
Australia's success in methadone treatment could guide Russia, UN says

Australia could prove critical in convincing Russia to change laws preventing heroin addicts from accessing opiate treatment programs, the UN secretary general’s special envoy for Aids in eastern Europe and central Asia said.

Published
24 July 2014
From
The Guardian
The moment that stunned Q&A’s AIDS audience

Monday night’s episode of panel discussion juggernaut Q&A was always going to be important. Yet the show was arguably stolen by Indonesian Health Minister Nafsiah Mboi, who has faced considerable backlash in her home country as the chair of The Global Fund to Fight AIDS, Tuberculosis and Malaria.

Published
23 July 2014
From
The New Daily
Harm reduction funding meeting only 7% of global need

International donors are investing only 7% of what is needed to provide adequate harm reduction coverage for people who inject drugs, according to findings from a report

Published
23 July 2014
By
Keith Alcorn
In The HIV Response, Who is ‘Hard to Reach’?

We have found that it is not the individuals at risk of HIV infection who are hard to reach. It’s the politicians and policymakers who adopt ideological rather than evidence-based programs. But HIV researchers too seem to be hard to reach at times, failing to investigate political determinants of health, and the impact of laws, policies, and enforcement on HIV vulnerability and access to care.

Published
23 July 2014
From
Human Rights Watch
IDU and HIV in the Middle East: a brief window of opportunity?

Pakistan saw rocketing levels of HIV (from near 0% to 23% in six months) following introduction of the infection into IDU populations. Low prevalence countries, including those about which we know little, may have only a brief “window of opportunity” before they experience a comparable explosion of HIV among their own IDU populations.

Published
22 July 2014
From
BMJ Group blogs
Recession and income inequality have fuelled HIV infections in European drug users

In European countries, increases in rates of reported HIV infections among people who inject drugs in recent years have been associated with the economic downturn and income

Published
21 July 2014
By
Roger Pebody
Funding for HIV prevention for people who inject drugs is in crisis, experts warn

Harm Reduction International, the International Drug Policy Consortium and the International HIV/Aids Alliance will publish a report that confirms HIV prevention services for drug injectors are losing out due to "changing donor policies and national government neglect".

Published
20 July 2014
From
The Observer
HIV Prevention in Clinical Care Settings - 2014 Recommendations of the International Antiviral Society–USA Panel

In an innovative approach to HIV prevention, an interdisciplinary group of experts has come together for the first time to lay out a framework of best practices to optimize the role of the clinician in achieving an AIDS-free generation.

Published
19 July 2014
From
Journal of the American Medical Association
← First12345...39Next →

Filter by country